XML 67 R52.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Loss Before Provision for Income Taxes
Our loss from continuing operations before income taxes (in thousands) was as follows:
For the Year Ended December 31,
202420232022
Domestic$(68,401)$(206,344)$(66,055)
Foreign5,365 3,939 3,978 
Loss from continuing operations before income taxes$(63,036)$(202,405)$(62,077)
Schedule of Components of Income Tax Expense (Benefit)
Components of income tax expense (benefit) (in thousands) consist of the following:
For the Year Ended December 31,
202420232022
Current
Federal$— $— $(875)
State and local125 2,855 1,788 
Foreign1,451 1,034 1,318 
Total current tax expense1,576 3,889 2,231 
Deferred
Federal(12,259)(42,156)5,055 
State and local(6,521)(12,822)(2,790)
Foreign(49)510 92 
Total deferred tax expense (benefit)(18,829)(54,468)2,357 
Change in valuation allowance15,840 (38,786)(47,964)
Total tax expense (benefit)$(1,413)$(89,365)$(43,376)
Schedule of Reconciliation of the U.S. Statutory Tax Rate to our Effective Tax Rate
A reconciliation of the U.S. statutory tax rate to our effective tax rate is presented below:
For the Year Ended December 31,
202420232022
U.S. statutory tax rate21.0 %21.0 %21.0 %
U.S. state income taxes, net of U.S. federal tax benefit3.6 %3.0 %(0.6)%
Foreign earnings at other than U.S. rates(0.3)%(0.3)%(0.8)%
Change in valuation allowance(25.1)%19.2 %77.3 %
Contingent consideration adjustments(2.9)%(1.2)%(0.1)%
Non-deductible excess compensation(8.1)%(6.8)%(27.8)%
Excess tax benefits on stock-based compensation4.8 %7.1 %12.2 %
Convertible debt extinguishment— %— %(3.4)%
Change in uncertain tax positions0.3 %(0.5)%(1.1)%
Nondeductible transaction costs(0.1)%(0.2)%(1.7)%
Change in state rate6.1 %2.2 %5.2 %
Return to provision and other deferred adjustments1.7 %(0.1)%(1.1)%
Tax receivable agreement0.3 %(0.9)%(9.1)%
Research and development tax credit - federal
1.2 %1.7 %— %
Other, net(0.3)%— %(0.1)%
Effective tax rate2.2 %44.2 %69.9 %
Schedule of Deferred Tax Assets and Liabilities
Significant components of the Company’s deferred tax assets and liabilities (in thousands) were as follows:
  As of December 31,
  20242023
Deferred Tax Assets
Start-up and organizational costs$38 $59 
Goodwill7,786 17,501 
Operating lease liabilities12,036 10,015 
Accrued expenses5,682 11,530 
Stock based compensation4,640 3,283 
Net operating loss carryforwards125,248 123,147 
Federal and state research tax credits5,014 4,467 
Fixed assets363 666 
Interest deduction limitation23,851 20,460 
Outside basis differences982 70 
Other7,890 7,417 
Subtotal193,530 198,615 
Valuation allowance(47,844)(32,004)
Total deferred tax assets145,686 166,611 
Deferred Tax Liabilities
Internally developed software costs2,384 5,697 
Intangible assets146,234 165,742 
Right-of-use assets - Operating670 1,884 
Contract fulfillment costs3,345 3,030 
Other2,453 2,606 
Total deferred tax liabilities155,086 178,959 
Net deferred tax liabilities (1)
$(9,400)$(12,348)
————————
(1)Amount is net of $1.5 million and $1.0 million of deferred tax assets included in prepaid expenses and other noncurrent assets on the consolidated balance sheets as of December 31, 2024 and 2023, respectively.

Changes in our valuation allowance (in thousands) were as follows:
For the Year Ended December 31,
20242023
Balance at beginning-of-year$32,004 $70,790 
Credited to costs and expenses15,840 (38,786)
Balance at end-of-year$47,844 $32,004 
Schedule of Changes in Unrecognized Tax Benefits
Changes in our unrecognized tax benefits (in thousands) were as follows:
For the Year Ended December 31,
202420232022
Balance at beginning-of-year$2,600 $1,624 $609 
Gross increases - tax positions in prior period— 616 
Gross decreases - tax positions in prior period(30)— — 
Gross increases - tax positions in current period232 969 399 
Lapse of statute of limitations(255)— — 
Balance at end-of-year$2,547 $2,600 $1,624